Camber launches generic Dacogen
Decitabine for injection is available in a 50 mg single-dose vial.
Pharmacy
Cofounder Tim Barry steps down as VillageMD CEO
Tim Barry, the co-founder and CEO of VillageMD, has left the company.
Camber launches Lidocaine Single Dose and Multi Dose Injections
This versatile product is available in various vial and pack sizes to meet diverse health care needs.
Swisslog Healthcare to showcase advanced pharmacy automation at ASHP Exhibition
Swisslog Healthcare will showcase its comprehensive range of pharmacy automation solutions, designed to streamline medication packaging, storage, and dispensing processes
Dr. Reddy's launches toripalimab in India
It is the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma.cd
Cencora to host inaugural Product Showcase
Event to highlight breadth of innovative capabilities, solutions and strategic partnerships that support healthcare continuum.
NACDS: Urgent need for PBM reform displayed again in Wall Street Journal
NACDS urges action this year to address "America's complicated - and costly - system for paying for medicines" as described in the article.
NACDS welcomes important action by New York State to hold PBM middlemen accountable
New York State Department of Financial Services adopts new market conduct regulations that will enable the regulatory oversight, transparency and accountability of PBMs operating in the state.
Trump tariffs to spike costs for most medical devices
GlobalData warns that President-elect Trump's proposed tariffs could raise prices and disrupt access to 75% of U.S. medical devices.
Biden administration wants Medicare, Medicaid to cover obesity drugs
Move would also ensure access to the medications for approximately 4 million adult Medicaid enrollees.
FDA approves BridgeBio Pharma's new heart drug
BridgeBio Pharma has received FDA approval for a new drug for a rare heart disease after very promising trials.
NY Gov. Hochul announces regulations on PBMs
Governor Kathy Hochul announced new regulations to govern Pharmacy Benefit Managers in New York. They aim to reduce prescription drug costs, increase transparency, and support small, independent pharmacies.
J & J seeks FDA nod for groundbreaking UC therapy
Johnson & Johnson has submitted an FDA application for the first subcutaneous IL-23 inhibitor for ulcerative colitis. This drug could offer patients a groundbreaking at-home treatment option.
NACDS poll: Voters say PBM reform is 'must-pass legislation'
A recent NACDS poll highlights strong voter support for PBM reform and the significant influence healthcare issues had on voters' decisions in the 2024 elections.